The 11^th German Pharm-Tox Summit (GPTS 2026) ↗ is a leading annual event bringing together researchers, clinicians, toxicologists, pharmacologists, and regulatory experts to discuss cutting-edge developments in pharmacology and toxicology. The scientific programme features sessions covering experimental and clinical pharmacology, novel toxicology models, mechanistic insights into adverse outcomes, integrated safety testing strategies, and translational approaches for regulatory science. The Summit also offers dedicated opportunities for early-career scientists to present their work and expand professional networks, as well as interactive discussions that bridge fundamental science with real-world safety and health applications. 

PARC will be represented by: 

• Neele Wewer ↗ (German Federal Institute for Risk Assessment) ↗ with two communications: “Combined Effects of Steatosis- and Phospholipidosis-Inducing Compounds on Lipid and Xenobiotic Metabolism in Human Liver Cells” and “Characterisation and Applicability of an In Vitro Liver Model Coculturing Four Different Cell Types in 3D”. 

For registration, programme details, and further information, please visit the official GPTS 2026 website ↗.